Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Factors associated with inappropriate chemical prophylaxis of thromboembolism in surgical patients.

Khorgami Z, Mofid R, Soroush A, Aminian A, Araghi NH, Hanafi S.

Clin Appl Thromb Hemost. 2014 Jul;20(5):493-7. doi: 10.1177/1076029612467844. Epub 2012 Dec 4.

PMID:
23223391
2.

Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.

Deheinzelin D, Braga AL, Martins LC, Martins MA, Hernandez A, Yoshida WB, Maffei F, Monachini M, Calderaro D, Campos W Jr, Sguizzatto GT, Caramelli B; Trombo Risc Investigators.

J Thromb Haemost. 2006 Jun;4(6):1266-70.

3.

Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.

Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators.

Thromb Haemost. 2012 Feb;107(2):280-7. doi: 10.1160/TH11-07-0464. Epub 2011 Dec 21.

PMID:
22186771
4.

[Caprini score as individual risk assessment model of postoperative venous thromboembolism in patients with high surgical risk].

Lobastov KV, Barinov VE, Schastlivtsev IV, Laberko LA.

Khirurgiia (Mosk). 2014;(12):16-23. Russian.

PMID:
25589313
5.

Thromboprophylaxis in surgical and medical patients.

Bozzato S, Galli L, Ageno W.

Semin Respir Crit Care Med. 2012 Apr;33(2):163-75. doi: 10.1055/s-0032-1311795. Epub 2012 May 30. Review.

PMID:
22648489
6.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

7.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
8.

Surgery in patients with hemophilia: is thromboprophylaxis mandatory?

Ozelo MC.

Thromb Res. 2012 Oct;130 Suppl 1:S23-6. doi: 10.1016/j.thromres.2012.08.265. Review.

PMID:
23026653
9.

An assessment of surgical thromboprophylaxis in a tertiary care center.

Robinson-Cohen C, Pilon D, Dubois MF, Tagalakis V.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E39-45. doi: 10.1177/1076029610382652. Epub 2010 Sep 9.

PMID:
20829273
11.

Prevention of venous thromboembolism after surgery.

Michota FA.

Cleve Clin J Med. 2009 Nov;76 Suppl 4:S45-52. doi: 10.3949/ccjm.76.s4.08. Review.

12.

Venous thromboembolism prevention in patients undergoing colorectal surgery for cancer.

Holwell A, McKenzie JL, Holmes M, Woods R, Nandurkar H, Tam CS, Bazargan A.

ANZ J Surg. 2014 Apr;84(4):284-8. doi: 10.1111/ans.12296. Epub 2013 Jun 19.

PMID:
23782713
13.

Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery.

Magee CJ, Barry J, Javed S, Macadam R, Kerrigan D.

Surg Obes Relat Dis. 2010 May-Jun;6(3):322-5. doi: 10.1016/j.soard.2010.02.046. Epub 2010 Mar 10.

PMID:
20510295
14.

[Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"].

Dávid M, Losonczy H, Udvardy M, Boda Z, Blaskó G, Tar A, Pfliegler G.

Orv Hetil. 2010 Aug 22;151(34):1365-74. doi: 10.1556/OH.2010.28944. Hungarian.

PMID:
20705551
15.

[Advancement of prophylaxis and therapy for venous thromboembolism].

Kobayashi T.

Rinsho Byori. 2008 Jul;56(7):589-99. Review. Japanese.

PMID:
18709991
16.

Venous thromboembolism risk and thromboprophylaxis among hospitalized patients: data from the Turkish arm of the ENDORSE study.

Ongen G, Yılmaz A, Cirak AK, Ersoy CY, Erden F, Altıntaş F, Yıldırım C, Güven H, Demir A, Kaynar L, Bastacı N, Demirtaş N.

Clin Appl Thromb Hemost. 2011 Oct;17(5):539-45. doi: 10.1177/1076029610382103. Epub 2010 Sep 9.

PMID:
20829272
17.

[Venous thromboembolism prophylaxis after general surgery: where are we now?].

Catania G, Di Stefano C, Ippolito G, Minona E, Alongi G, Cardì F.

G Chir. 2011 Apr;32(4):206-10. Italian.

PMID:
21554853
18.

Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?

Bouchard-Fortier G, Geerts WH, Covens A, Vicus D, Kupets R, Gien LT.

Gynecol Oncol. 2014 Aug;134(2):228-32. doi: 10.1016/j.ygyno.2014.05.012. Epub 2014 May 27.

PMID:
24875122
19.

Need to improve thromboprophylaxis across the continuum of care for surgical patients.

Amin AN, Lin J, Ryan A.

Adv Ther. 2010 Feb;27(2):81-93. doi: 10.1007/s12325-010-0015-8.

PMID:
20390389
20.

Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.

Farias-Eisner R, Horblyuk R, Franklin M, Lunacsek OE, Happe LE.

Curr Med Res Opin. 2009 May;25(5):1081-7. doi: 10.1185/03007990902837117 .

PMID:
19298219

Supplemental Content

Support Center